← All trials
NCT05781243
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 19, 2023
- Primary completion
- Apr 1, 2026
- Completion date
- Apr 1, 2026
- First posted
- Mar 23, 2023
- Last posted
- Sep 25, 2023
- Enrollment
- 720
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University AlicanteLead sponsor
- University of AthensCollaborator
- Corporacion Parc TauliCollaborator
- Mario Negri InstituteCollaborator
- Hayatabad Medical ComplexCollaborator
- University of Santiago de CompostelaCollaborator
- University of ValenciaCollaborator
- Hospital Clinico Lozano BlesaCollaborator
- Hospital Costa del SolCollaborator
- Universidad Autonoma de BarcelonaCollaborator
- University AlicanteSponsor investigator
- Hospital General Universitario Gregorio MarañonCollaborator
- University of ZaragozaCollaborator
- Hospital Regional Alta Especialidad BajioCollaborator
- University of BurgosCollaborator
- University of ValenciaCollaborator
- Hospital Universitario Lucus AugustiCollaborator
- University of CantabriaCollaborator
- Hospital Universitario Puerta del MarCollaborator
- Hospital Universitario Ramon y CajalCollaborator
- Universitario de la PrincesaCollaborator
- Universidad Carlos III MadridCollaborator
- Miguel Hernández UniversityCollaborator
- Palacky UniversityCollaborator
- University Hospital "Sestre Milosrdnice"Collaborator
- University Hospital Virgen de las NievesCollaborator
- Zagazig UniversityCollaborator
- King Hamad UniversityCollaborator
- Ohio State UniversityCollaborator
- Asian Institute Of Medical SciencesCollaborator
- Wannan Medical CollegeCollaborator
- Hospital Privado de Cordoba, ArgentinaCollaborator
- RML Specialty HospitalCollaborator
- University of UtahCollaborator
- Zhengzhou UniversityCollaborator
- University of SevilleCollaborator
- Hospital Universitario Central de AsturiasCollaborator
- University of ValladolidCollaborator
- Henan Medical UniversityCollaborator
- Clinica Universidad de NavarraCollaborator
- City University of Hong KongCollaborator
- Kalinga Hospital, BhubaneswarCollaborator
- Jinlin UniversityCollaborator
- Bucharest Emergency HospitalCollaborator
- Institut d'Investigació Biomèdica de Girona Dr. Josep TruetaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.